Publication of List of Manufacturers Revoked from Licensing for the Manufacture of Therapeutic Goods - E L Bell Packaging Pty Ltd

Overview

The Therapeutic Goods Act 1989, enacted to regulate the importation, supply, manufacture, and advertising of therapeutic goods in Australia, was introduced to address the need for a comprehensive framework to ensure the safety, quality, and efficacy of therapeutic goods. The Act provides mechanisms for the regulation of therapeutic goods through licensing and other regulatory processes. This particular gazette, C2013G00075, was issued under the authority of the Therapeutic Goods Act 1989 by Bill Turner, acting as a delegate of the Secretary. The revocation of the manufacturing licence held by E L BELL PACKAGING PTY LTD, announced in the gazette, was carried out at the request of the manufacturer and reflects the Act's objective to maintain the integrity and reliability of the therapeutic goods market. The revocation process is one way in which the Therapeutic Goods Administration can respond to non-compliance or other issues related to the manufacture of therapeutic goods in Australia.

Scope and Application

The Therapeutic Goods Act 1989, as part of its regulatory framework for the manufacture and supply of therapeutic goods in Australia, encompasses a range of provisions that ensure the safety and quality of such goods. This Act applies to any person or entity involved in the manufacture, import, supply, or advertisement of therapeutic goods within Australia. This includes pharmaceutical drugs, medical devices, and other health-related products. The scope of the Act is national, with its provisions extending across the Commonwealth, states, and territories of Australia. Notably, the Act allows for the exclusion of certain goods through subordinate instruments, which can specify exemptions or thresholds based on the nature and risk profile of the therapeutic goods in question. In this instance, the Act facilitated the revocation of a manufacturer's licence, as evidenced by the notice published concerning E L BELL PACKAGING PTY LTD, illustrating the Act's capacity to enforce compliance through administrative actions.

Key Provisions

The Therapeutic Goods Act 1989 includes provisions that allow the Secretary to revoke a licence to manufacture therapeutic goods under certain conditions (section 41). In this case, the Secretary has revoked the licence held by E L BELL PACKAGING PTY LTD (licence number MI-09112004-LI-000143-1) at the request of the manufacturer. This revocation is in accordance with paragraph 41(1)(d) of the Act, which provides the legal basis for such actions. The revocation of the licence imposes obligations on the manufacturer, E L BELL PACKAGING PTY LTD, to cease any manufacturing activities related to therapeutic goods immediately. The manufacturer must also comply with any further instructions or conditions stipulated by the Secretary in relation to the revocation. This might include returning any materials or products that are subject to the licence or ensuring that the manufacturing facilities are no longer used for the production of therapeutic goods. The manufacturer is required to notify relevant stakeholders of the revocation and to ensure that all records are maintained as per the Act’s requirements. Failure to comply with the revocation of the licence can result in various penalties and consequences. Under the Therapeutic Goods Act 1989, any person who contravenes the provisions of the Act can be subject to civil penalties, including fines. In more serious cases, criminal offences can be charged, leading to prosecution and potential imprisonment. The specific penalties for breaches are detailed within the Act, and can vary depending on the severity and circumstances of the breach. For example, under section 62 of the Act, a person can be fined up to $162,000 for offences related to the manufacture of therapeutic goods without the requisite licence. These penalties serve as a deterrent to ensure compliance with the legislative requirements governing the manufacture of therapeutic goods in Australia.